Literature DB >> 26978124

Adherence of Primary Care Physicians to Evidence-Based Recommendations to Reduce Ovarian Cancer Mortality.

Sherri L Stewart1, Julie S Townsend1, Mary C Puckett1, Sun Hee Rim1.   

Abstract

Ovarian cancer is the deadliest gynecologic cancer. Receipt of treatment from a gynecologic oncologist is an evidence-based recommendation to reduce mortality from the disease. We examined knowledge and application of this evidence-based recommendation in primary care physicians as part of CDC gynecologic cancer awareness campaign efforts and discussed results in the context of CDC National Comprehensive Cancer Control Program (NCCCP). We analyzed primary care physician responses to questions about how often they refer patients diagnosed with ovarian cancer to gynecologic oncologists, and reasons for lack of referral. We also analyzed these physicians' knowledge of tests to help determine whether a gynecologic oncologist is needed for a planned surgery. The survey response rate was 52.2%. A total of 84% of primary care physicians (87% of family/general practitioners, 81% of internists and obstetrician/gynecologists) said they always referred patients to gynecologic oncologists for treatment. Common reasons for not always referring were patient preference or lack of gynecologic oncologists in the practice area. A total of 23% of primary care physicians had heard of the OVA1 test, which helps to determine whether gynecologic oncologist referral is needed. Although referral rates reported here are high, it is not clear whether ovarian cancer patients are actually seeing gynecologic oncologists for care. The NCCCP is undertaking several efforts to assist with this, including education of the recommendation among women and providers and assistance with treatment summaries and patient navigation toward appropriate treatment. Expansion of these efforts to all populations may help improve adherence to recommendations and reduce ovarian cancer mortality.

Entities:  

Mesh:

Year:  2016        PMID: 26978124      PMCID: PMC5289707          DOI: 10.1089/jwh.2015.5735

Source DB:  PubMed          Journal:  J Womens Health (Larchmt)        ISSN: 1540-9996            Impact factor:   2.681


  29 in total

1.  Involvement of gynecologic oncologists in the treatment of patients with a suspicious ovarian mass.

Authors:  Barbara A Goff; Jacqueline W Miller; Barbara Matthews; Katrina F Trivers; C Holly A Andrilla; Denise M Lishner; Laura-Mae Baldwin
Journal:  Obstet Gynecol       Date:  2011-10       Impact factor: 7.661

2.  Impact of a multivariate index assay on referral patterns for surgical management of an adnexal mass.

Authors:  Robert E Bristow; Melissa Hodeib; Alan Smith; Daniel W Chan; Zhen Zhang; Eric T Fung; Krishnansu S Tewari; Donald G Munroe; Frederick R Ueland
Journal:  Am J Obstet Gynecol       Date:  2013-08-11       Impact factor: 8.661

Review 3.  Teleoncology for gynecologic cancers.

Authors:  David I Shalowitz; Allison G Smith; Maria C Bell; Randall K Gibb
Journal:  Gynecol Oncol       Date:  2015-07-05       Impact factor: 5.482

4.  The choice is yours? How women with ovarian cancer make sense of treatment choices.

Authors:  Sue Ziebland; Julie Evans; Ann McPherson
Journal:  Patient Educ Couns       Date:  2006-07-28

5.  Geographic disparities amongst patients with gynecologic malignancies at an urban NCI-designated cancer center.

Authors:  Sarah M Temkin; Saroj A Fleming; Selma Amrane; Nicholas Schluterman; Mishka Terplan
Journal:  Gynecol Oncol       Date:  2015-03-17       Impact factor: 5.482

6.  Breast-feeding and risk of epithelial ovarian cancer.

Authors:  S J Jordan; K L Cushing-Haugen; K G Wicklund; J A Doherty; M A Rossing
Journal:  Cancer Causes Control       Date:  2012-04-24       Impact factor: 2.506

7.  Effect of surgeon specialty on processes of care and outcomes for ovarian cancer patients.

Authors:  Craig C Earle; Deborah Schrag; Bridget A Neville; K Robin Yabroff; Marie Topor; Angela Fahey; Edward L Trimble; Diane C Bodurka; Robert E Bristow; Michael Carney; Joan L Warren
Journal:  J Natl Cancer Inst       Date:  2006-02-01       Impact factor: 13.506

Review 8.  Gynecologic cancer prevention and control in the National Comprehensive Cancer Control Program: progress, current activities, and future directions.

Authors:  Sherri L Stewart; Naheed Lakhani; Phaeydra M Brown; O Ann Larkin; Angela R Moore; Nikki S Hayes
Journal:  J Womens Health (Larchmt)       Date:  2013-07-18       Impact factor: 2.681

9.  Patients' preferences in mode of surgery of an adnexal mass.

Authors:  Peggy M A J Geomini; Gérard L Bremer; Roy F P M Kruitwagen; Brent C Opmeer; Ben Willem J Mol
Journal:  J Psychosom Obstet Gynaecol       Date:  2009-09       Impact factor: 2.949

10.  Meeting the Healthy People 2020 Objectives to Reduce Cancer Mortality.

Authors:  Hannah K Weir; Trevor D Thompson; Ashwini Soman; Bjorn Møller; Steven Leadbetter; Mary C White
Journal:  Prev Chronic Dis       Date:  2015-07-02       Impact factor: 2.830

View more
  4 in total

1.  Disparities in ovarian cancer survival in the United States (2001-2009): Findings from the CONCORD-2 study.

Authors:  Sherri L Stewart; Rhea Harewood; Melissa Matz; Sun Hee Rim; Susan A Sabatino; Kevin C Ward; Hannah K Weir
Journal:  Cancer       Date:  2017-12-15       Impact factor: 6.860

2.  Patient and Provider Perspectives on Barriers to Accessing Gynecologic Oncologists for Ovarian Cancer Surgical Care.

Authors:  Kristin Weeks; Michele West; Charles Lynch; Lisa Hunter; Chelsea Keenan; Savannah Borman; Megan McDonald; Mary Charlton
Journal:  Womens Health Rep (New Rochelle)       Date:  2020-12-28

3.  Association of Distance to Gynecologic Oncologist and Survival in a Rural Midwestern State.

Authors:  Keely K Ulmer; Breanna Greteman; Megan McDonald; Jesus Gonzalez Bosquet; Mary E Charlton; Sarah Nash
Journal:  Womens Health Rep (New Rochelle)       Date:  2022-08-04

4.  Rural disparities in surgical care from gynecologic oncologists among Midwestern ovarian cancer patients.

Authors:  Kristin Weeks; Charles F Lynch; Michele West; Ryan Carnahan; Michael O'Rorke; Jacob Oleson; Megan McDonald; Sherri L Stewart; Mary Charlton
Journal:  Gynecol Oncol       Date:  2020-11-18       Impact factor: 5.482

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.